Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function.

Valentina Folgiero1, Robin E Bachelder, Giulia Bon

  • 1Molecular Oncogenesis Laboratory, Department of Experimental Oncology, Regina Elena Cancer Institute, Via della Messi d'Oro 156, 00158 Rome, Italy.

Cancer Research
|February 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma" [Exp Mol Pathol Volume 146, June 2026, 105049].

Experimental and molecular pathology·2026
Same author

A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma.

Experimental and molecular pathology·2026
Same author

Folate Receptor α Contributes to Radiation Resistance in Neuroendocrine Prostate Cancer by Regulating Redox Homeostasis.

bioRxiv : the preprint server for biology·2026
Same author

The Role of Protein Kinases in the Management of Oncological Diseases by Acting on Ferroptotic Pathways.

International journal of molecular sciences·2026
Same author

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer.

Molecular oncology·2026
Same author

Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Integrin alpha(6)beta(4) promotes carcinoma cell survival by regulating ErbB-3 expression, enhancing the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. This mechanism involves translational control, impacting cancer cell apoptosis.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Integrin alpha(6)beta(4) is crucial for carcinoma cell functions like migration, invasion, and apoptosis evasion.
  • The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is a key mediator of alpha(6)beta(4) signaling in cancer.
  • alpha(6)beta(4) signaling is closely linked to growth factor receptors, particularly ErbB family members.

Purpose of the Study:

  • To elucidate the mechanism by which alpha(6)beta(4) influences cancer cell signaling pathways.
  • To investigate the role of alpha(6)beta(4) in regulating ErbB-3 expression and its downstream effects.
  • To understand how alpha(6)beta(4) impacts the activation of the PI3K/Akt pathway and apoptosis in carcinoma cells.

Main Methods:

  • Utilized multiple cancer cell models to study alpha(6)beta(4) effects.

Related Experiment Videos

  • Analyzed ErbB-3 expression at both mRNA and protein levels.
  • Investigated the role of rapamycin and eukaryotic translation initiation factor 4E in alpha(6)beta(4)-mediated regulation.

    • Main Results:

    • Demonstrated that alpha(6)beta(4) regulates ErbB-3 expression, leading to ErbB-2/ErbB-3 heterodimer formation.
    • Showed that this heterodimerization enhances alpha(6)beta(4)-dependent activation of the PI3K/Akt pathway.
    • Found that alpha(6)beta(4) inhibits carcinoma cell apoptosis through this signaling axis.
    • Evidence suggests alpha(6)beta(4) regulates ErbB-3 at the translational level, independent of significant mRNA changes.

    Conclusions:

    • alpha(6)beta(4) promotes carcinoma cell survival by upregulating ErbB-3 expression translationally.
    • The formation of ErbB-2/ErbB-3 heterodimers is a key step in alpha(6)beta(4)-mediated PI3K/Akt activation.
    • This pathway provides a novel mechanism for alpha(6)beta(4) to impede apoptosis in cancer cells.